Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Untch

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Cancer Research|May 16, 2018
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid CancersBrian R Untch, Vanessa Dos Anjos, Maria E R Garcia-Rendueles, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2011
Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptorJames Koh, Moahad Dar, Brian R Untch, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2019
Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node MetastasesDilmi Perera, Ronald Ghossein, Niedzica Camacho, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 23, 2014
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumorsBrian R Untch, Keisha P Bonner, Kevin K Roggin, et al.
Annals of Surgical Oncology|November 25, 2015
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control StudyEran Sadot, Diane L Reidy-Lagunes, Laura H Tang, et al.
Nature Communications|October 14, 2018
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroupChang S Chan, Saurabh V Laddha, Peter W Lewis, et al.
Surgery|October 27, 2018
Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodulesAndrea R Marcadis, Pablo Valderrabano, Allen S Ho, et al.
Molecular Cancer Research : MCR|October 12, 2021
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor TherapyMark Lee, Brian R Untch, Bin Xu, et al.
Pancreas|June 14, 2017
The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor SocietyJames R Howe, Kenneth Cardona, Douglas L Fraker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
PD-1 Blockade in Advanced Adrenocortical CarcinomaNitya Raj, Youyun Zheng, Virginia Kelly, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Cancer Research|May 16, 2018
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid CancersBrian R Untch, Vanessa Dos Anjos, Maria E R Garcia-Rendueles, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2011
Regulator of G protein signaling 5 is highly expressed in parathyroid tumors and inhibits signaling by the calcium-sensing receptorJames Koh, Moahad Dar, Brian R Untch, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2019
Genomic and Transcriptomic Characterization of Papillary Microcarcinomas With Lateral Neck Lymph Node MetastasesDilmi Perera, Ronald Ghossein, Niedzica Camacho, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 23, 2014
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumorsBrian R Untch, Keisha P Bonner, Kevin K Roggin, et al.
Annals of Surgical Oncology|November 25, 2015
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control StudyEran Sadot, Diane L Reidy-Lagunes, Laura H Tang, et al.
Nature Communications|October 14, 2018
ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroupChang S Chan, Saurabh V Laddha, Peter W Lewis, et al.
Surgery|October 27, 2018
Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodulesAndrea R Marcadis, Pablo Valderrabano, Allen S Ho, et al.
Molecular Cancer Research : MCR|October 12, 2021
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor TherapyMark Lee, Brian R Untch, Bin Xu, et al.
Pancreas|June 14, 2017
The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor SocietyJames R Howe, Kenneth Cardona, Douglas L Fraker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2019
PD-1 Blockade in Advanced Adrenocortical CarcinomaNitya Raj, Youyun Zheng, Virginia Kelly, et al.
Pageof 5